Richard Thomas Williams serves as Executive at Kinnate Biopharma Inc., where they oversee executive responsibilities. Since joining the company, Richard Thomas Williams has executed 9 insider transactions totaling $338.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 1, 2024 involved selling 558 shares valued at $1.4K.
Richard Thomas Williams currently holds 67,588 shares of Kinnate Biopharma Inc. (KNTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Thomas Williams has been a net buyer of KNTE stock. They have purchased $338.9K and sold $0 worth of shares.
Richard Thomas Williams's most recent insider trade was on Mar 1, 2024, when they sold 558 shares at $2.59 per share.
Get notified when new Form 4 filings are submitted
| $2.25 |
| Discretionary |
| Sep 1, 2023 | KNTE | $1.3K | Payment | 541 | $2.35 | Discretionary |
| Jun 1, 2023 | KNTE | $2.3K | Payment | 541 | $4.30 | Discretionary |
| Mar 1, 2023 | KNTE | $3.3K | Payment | 638 | $5.21 | Discretionary |
| Dec 1, 2022 | KNTE | $4.2K | Payment | 541 | $7.75 | Discretionary |
| Sep 1, 2022 | KNTE | $0 | Award | 25,000 | $N/A | Discretionary |
| Mar 14, 2022 | KNTE | $209.3K | Purchase | 25,000 | $8.37 | Discretionary |
| Mar 11, 2022 | KNTE | $129.6K | Purchase | 15,000 | $8.64 | Discretionary |